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Abstract
Objective—To identify predictors and outcomes associated with a birth weight of 4000 g or
more in Lusaka, Zambia.
Methods—Data from women who delivered between February 2006 and August 2011 were
obtained from electronic perinatal records at 25 public sector facilities in Lusaka. Macrosomia was
defined as a birth weight of 4000 g or more and normal birth weight as 2500–3999 g. Maternal
and newborn characteristics were analyzed for association with macrosomia.
Results—There were 4717 macrosomic and 187 117 normal birth weight newborns. The
strongest predictors of macrosomia were high BMI (adjusted odds ratio [AOR], 2.88; 95%
confidence interval [CI], 1.95–4.24), prior macrosomic newborn (AOR, 7.60; 95% CI, 6.81–8.49),
and history of diabetes (AOR, 3.09; 95% CI, 1.36–6.98). Macrosomic newborns were at increased
risk for cesarean delivery (AOR, 1.63; 95% CI, 1.35–1.96), fresh stillbirth (AOR, 2.24; 95% CI,
1.56–3.21), Apgar score of under 7 at 5 minutes (AOR, 2.03; 95% CI, 1.33–3.11), and neonatal
intensive care admission (AOR, 2.07; 95% CI, 1.32–3.23).
Conclusion—Screening for macrosomia should be considered for high-risk patients in Sub-
Saharan Africa. Institutional delivery at facilities with operating rooms and neonatal intensive care
services should be encouraged.
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1. Introduction
Fetal macrosomia is associated with an increased risk of morbidity and mortality to both the
pregnant woman and her newborn. Maternal complications include higher rates of cesarean
delivery [1,2] and third and fourth degree perineal lacerations during vaginal delivery [2–4].
Potential newborn complications include perinatal mortality, shoulder dystocia, and birth
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asphyxia [1,5]. Where access to cesarean delivery is limited, macrosomia increases the
probability of maternal death from obstructed labor, sepsis, and/or postpartum hemorrhage
[5,6].
In high-income countries, the prevalence of fetal macrosomia is a public health issue of
growing concern. Mean newborn birth weight has steadily risen over the past 4 decades in
Europe, North America, and Australia, as has the relative number of macrosomic newborns
[4,7–11]. Increased maternal body mass index (BMI) and decreased cigarette smoking have
been proposed as reasons behind this trend [12,13]. By contrast, fewer data are available for
lower-income countries, particularly in Sub-Saharan Africa where the prevalence of
overweight and obese adults is also on the rise [14]. A better understanding of the clinical
epidemiology of fetal macrosomia would greatly inform obstetric care in such resource-
constrained settings.
Lusaka, Zambia, is a city that has a population of approximately 2 million and has an
extensive public-sector network for prenatal and postnatal services across 25 facilities. Most
pregnant women deliver at 13 of these sites, which include the tertiary referral hospital
University Teaching Hospital. The Zambian national guidelines regarding pregnancy,
childbirth, postpartum, and newborn care are based on recommendations by the WHO that
promote focused prenatal care comprising 4 routine visits and facility delivery by a skilled
birth attendant [15]. Although higher risk pregnancies are referred to specialist doctors
stationed at hospitals, nearly all maternal care in the country’s capital is provided by
midwives. The aim of the present study was to identify predictors and adverse outcomes
associated with fetal macrosomia in public-sector health centers in Lusaka, Zambia.
2. Materials and methods
Retrospective data from women who established prenatal care and delivered within the
public sector in Lusaka, Zambia, between February 1, 2006, and August 31, 2011, were
analyzed. Data were obtained from the Zambia Electronic Perinatal Record System
(ZEPRS), a networked patient-level electronic medical record system that captures
information regarding prenatal care, labor and delivery, and postnatal care [16] and that is
used in all 24 primary care sites and University Teaching Hospital in Lusaka. Use of these
routinely collected clinical data was approved by ethical review committees at the
University of Zambia; the University of Alabama at Birmingham, USA, and the University
of North Carolina at Chapel Hill, USA. Owing to the retrospective nature of the study,
informed consent was not obtained.
Mother–newborn pairs were categorized according to the newborn’s birth weight. Although
multiple definitions have been proposed, a newborn birth weight of 4000 g or more was
classified as fetal macrosomia [4] and these newborns were not graded further [17] in the
present study. The comparison group comprised only newborns with a birth weight between
2500 g and 3999 g. Newborns under 2500 g at birth were not included in the analysis.
Because estimates of gestational age can be inaccurate in the study setting, newborns with a
lower birth weight probably comprise a heterogeneous group of preterm deliveries and
growth-restricted newborns. Multiple gestations were excluded for similar reasons.
Maternal demographic and clinical information that are routinely captured at the first
prenatal visit were examined. Historical data, such as prior delivery of a macrosomic
newborn, prior stillbirth, previous newborn death (at <1 year), and personal or family history
of diabetes mellitus, were ascertained by self-report. BMI (calculated as weight in kilograms
divided by the square of height in meters) was determined for those women whose weight
and height were documented at the first prenatal visit. Other potential risk factors were
evaluated for fetal macrosomia including maternal age at first prenatal visit, highest level of
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maternal education attained, parity, maternal weight of 90 kg or more at first prenatal visit,
chronic hypertension, and sex of newborn.
Several outcome measures were considered. Hypertensive disorders of pregnancy were
defined by any one of the following: a systolic blood pressure of 140 mm Hg or higher after
20 weeks of gestation, a diastolic blood pressure 90 mm Hg or higher after 20 weeks of
gestation, or documented diagnosis of pre-eclampsia or eclampsia in the medical record.
Maternal mortality included prepartum, intrapartum, and postpartum deaths that were
recorded in ZEPRS.
Stillbirths were diagnosed and classified by health providers attending the delivery. A
macerated stillbirth was defined as a neonate born dead with degenerative skin changes, as
recorded by the delivering clinician, and was presumed to have occurred 12 hours or more
before delivery. A fresh stillbirth lacked such skin changes and probably occurred within 12
hours of delivery. Descriptions of neonatal death were limited to the early period of 7 days
or fewer after birth; ascertainment of neonatal deaths was generally poor after this 1-week
threshold, especially when newborns were readmitted after initial hospital discharge.
Other outcomes, all of which were extracted from individual medical records, were mode of
delivery, cephalopelvic disproportion or dystocia as an indication for cesarean delivery,
perineal laceration, postpartum hemorrhage, any other maternal complication (including a
range of diagnoses from septicemia to renal failure), an Apgar score at 5 minutes of less than
7, and admission to the neonatal intensive care unit (NICU). The outcomes of stillbirth,
cesarean delivery, and NICU admission were also compared according to 4 birth weight
categories: 2500–2999 g, 3000–3999 g, 4000–4499 g, and 4500 g or more.
All analyses were conducted via SAS version 9.1 (SAS Institute, Cary, NC, USA). Maternal
and newborn predictors and pregnancy outcomes were analyzed for association with
macrosomia via Pearson χ2 test, Wilcoxon rank-sum test, and logistic regression to convey
the crude odds ratio (COR) with corresponding 95% confidence interval (CI). For
continuous variables, medians and interquartile ranges (IQR) were determined; for
categorical variables, percentages were calculated.
An adjusted odds ratio (AOR) was calculated by using a generalized linear model with a
binomial family of distributions and logit link function accounting for repeated measures of
multiple pregnancies. Maternal and newborn characteristics that were significant at a P value
of less than 0.05 were included in the multivariable regression. When 2 variables showed
high correlation with each another, only 1 was selected for inclusion in the model.
3. Results
During the study period, 219 780 documented newborn deliveries with at least 1 prenatal
visit were recorded in ZEPRS (Fig. 1). Of these, 216 026 (98.3%) newborns were singletons.
The birth weight distribution of all 213 357 singletons with a documented birth weight
ranged from 100 g to 6000 g with a mean birth weight of 3005 ± 501.6 g (Fig. 2). For the
analysis, 21 523 (10.0%) newborns weighing less than 2500 g and 2669 (1.2%) newborns
with missing birth weight data were excluded.
For the 191 834 women included in the analysis cohort, the median maternal age at the first
prenatal visit was 25 years (IQR, 21–29 years), the median parity was 1 (IQR, 0–3 years),
and the median baseline BMI was 23.5 (IQR, 21.5–26.2). Among the 191 834 singletons
included in the analysis, 4717 (2.5%) weighed more than 4000 g and were thus categorized
as macrosomic.
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Compared with women delivering a newborn weighing 2500–3999 g, women who gave
birth to macrosomic newborns were older and more educated, and had higher parity (P <
0.01) (Table 1). They also had a higher baseline BMI (P < 0.01). Other risk factors that were
significant included maternal weight of more than 90 kg at first prenatal visit, prior newborn
weighing 4000 g or more, prior stillbirth, previous death of infant younger than 1 year,
personal or family history of diabetes mellitus, chronic hypertension, and male sex of
newborn. Several risk factors remained significant in the multivariable analysis (Table 2).
The strongest predictors of macrosomia were baseline BMI of 30 or more, prior newborn
weighing 4000 g or more, and personal or family history of diabetes mellitus.
Pregnancy outcomes were evaluated for macrosomic newborns (Table 3). Compared with
newborns weighing 2500–3999 g, macrosomic newborns were at increased risk for cesarean
delivery, and cephalopelvic disproportion or dystocia was a more likely indication for
cesarean delivery in fetal macrosomia. Women with macrosomic newborns were more likely
than women with newborns weighing 2500–3999 g to develop hypertensive disorders of
pregnancy. Macrosomic newborns were at increased risk for fresh stillbirth, low Apgar score
(<7) at 5 minutes, and NICU admission compared with newborns weighing 2500–3999 g at
birth. No significant differences were observed between the groups for other complications,
including perineal laceration, postpartum hemorrhage, maternal mortality, and early
neonatal death.
The frequency of stillbirth, cesarean delivery, and NICU admission were stratified by birth
weight (Fig. 3). Among the 4 categories, newborns weighing 3000–3999 g seemed to have
the lowest risk for stillbirth and NICU admission, whereas those weighing 4500 g or more
seemed to have the highest risk. The proportion of cesarean deliveries increased as the birth
weight increased: the highest incidence of cesarean delivery (20.2%) occurred for newborns
weighing 4500 g or more.
4. Discussion
In the present population-based study of approximately 200 000 deliveries in Lusaka,
Zambia, there was a 2.5% prevalence of fetal macrosomia among singletons weighing 2500
g or more. Macrosomia was associated with increased risk for cesarean delivery and
perinatal complications such as fresh stillbirth, low Apgar score, and NICU admission. The
findings show clear associations between specific maternal characteristics and fetal
macrosomia, suggesting potential targets for public health interventions.
The strength of the present analysis is its population-based approach. All public sector
facilities—where most women seek prenatal care in Lusaka—were included rather than a
single clinic or referral hospital [1,5,18,19]. However, the study has several limitations.
First, similar to other studies that limited their comparison group by weight instead of
gestational age and weight [1,18], newborns weighing less than 2500 g were excluded.
Because small-for-gestational-age term neonates, who may have increased morbidity and
mortality, were not considered, the comparison group might have been enriched with
healthier newborns. Second, only facility-based deliveries and their outcomes were reported.
Macrosomic newborns who are delivered at home probably have worse outcomes, given the
lack of neonatal monitoring and timely operative delivery [20]. Third, results from the
present urban-based cohort may not be applicable to rural sites. The capacity for cesarean
delivery and NICU referrals, for example, is likely to have improved perinatal outcomes.
Studies have also shown that women living in urban settings have higher average weights
than those in rural areas, a finding that could influence the baseline distribution of birth
weight [21]. Fourth, the present analysis used programmatic data captured in routine clinical
settings and probably underreports the frequency of complications in general. Last,
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screening and diagnostic testing for co-morbidities is limited in the study setting. Untreated
gestational diabetes, for example, might also be an important predictor of fetal macrosomia;
however, it was not possible to establish such links owing to a paucity of routine screening
to determine the prevalence of this disease.
Macrosomia in the study cohort was at the lower range of reported prevalence in Africa
(2.5%–14.7%) [5,18,22]; however, most African studies on fetal macrosomia originate from
settings in West Africa that may be different in terms of urbanization and resources. In
addition, unlike many hospital-based studies, the relatively low prevalence of macrosomia
may reflect the general prenatal population who deliver at the Lusaka network of primary
care centers. Despite the low prevalence of macrosomia, the predictors for high birth weight
were consistent with those of other studies carried out both in the region and in high-
resource countries [1,5,19,22].
The study showed that maternal and neonatal complications were increased for newborns
weighing 4000 g or more. Macrosomic newborns were at higher risk for cesarean delivery
compared with normal birth weight newborns: the incidence of cesarean delivery was higher
than 20% when the birth weight was 4500 g or more. Similar increases in cesarean delivery
have been previously reported [1,18], although not all studies are consistent [5]. In line with
other reports [1,5,18], perinatal mortality and NICU admission increased for macrosomic
newborns. Clinical interventions around the time of delivery might reduce the rate of
perinatal mortality in cases of fetal macrosomia.
In the present cohort, women with risk factors for gestational diabetes were at increased risk
of delivering a macrosomic newborn. Because the timely diagnosis and treatment of
gestational diabetes can reduce the risk of fetal macrosomia and other perinatal
complications [23], targeted screening should be considered in settings where routine testing
is not feasible. While the International Association of the Diabetes and Pregnancy Study
Groups allows flexibility for local implementation of such screening [24], some form of
prenatal testing for gestational diabetes mellitus [1,5,25] should be prioritized, particularly
as obesity is increasing in many African and Asian countries. Future research should include
feasibility studies and cost–benefit analyses of screening, whether routine or targeted, for
gestational diabetes in resource-limited settings. Interventions such as nutrition counseling
and oral hypoglycemic agents should also be examined for effectiveness and cost–benefit in
Sub-Saharan Africa.
The present results show that fetal macrosomia is associated both with risk factors that are
easy to screen and with poor pregnancy outcomes that may benefit from early referral. More
rigorous screening of predictors to identify and potentially prevent fetal macrosomia should
be adopted. Although maternal diabetes is the most common cause of fetal macrosomia,
modifiable risk factors include pre-pregnancy maternal weight, maternal weight gain during
pregnancy, and delivery after 40 weeks of gestation. Public health campaigns and group
health education should focus more on nutrition in reproductive age women. Whenever
possible, delivery should occur at facilities with cesarean delivery capacity and/or neonatal
intensive care. Targeted public health interventions aimed at reducing fetal macrosomia in
resource-limited settings might help to meet Millennium Development Goal 5 by closing
each gap that contributes to maternal and perinatal morbidity and mortality.
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Study flow diagram for the inclusion of data on macrosomic neonates born in Lusaka,
Zambia, between February 2006 and August 2011.
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Distribution of birth weight for singletons born in Lusaka, Zambia, between February 2006
and August 2011 (n = 216 026). The birth weight distribution is divided by 100-g intervals
and reflects all singleton newborns with birth weight documented in ZEPRS. The lighter-
colored bars represent newborns with a birth weight of less than 2500 g who were excluded
from the analysis.
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Frequencies and percentages of stillbirth, cesarean delivery, and NICU admission according
to birth weight band. Data were obtained from ZEPRS for neonates born in Lusaka, Zambia,
between February 2006 and August 2011 (n = 191 834).
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Table 1
Maternal and newborn characteristics among normal birth weight and macrosomic pregnancies in Lusaka,
Zambia (n = 191 834).a
Characteristic Birth weight 2500–3999 g (n = 187 117) Birth weight ≥4000 g (n = 4717) P value
Maternal age, y 25 (21–29) 28 (24–32) <0.01d
 <20 33 675 (18.0) 268 (5.7) <0.01e
 20–34 139 431 (74.5) 3847 (81.6)
 ≥35 14 011 (7.5) 602 (12.8)
Maternal education
 None or primary 73 101 (45.3) 1719 (40.9) <0.01e
 Secondary and higher 88 178 (54.7) 2483 (59.1)
Parityb 1 (0–3) 2 (1–3) <0.01d
 0 51 095 (29.3) 547 (12.7) <0.01e
 1–4 114 136 (65.6) 3,362 (78.4)
 ≥5 8879 (5.1) 382 (8.9)
Baseline BMIc 23.5 (21.5–26.1) 26.2 (23.4–29.8) <0.01d
 <18.5 3289 (2.8) 41 (1.4) <0.01e
 18.5–24.9 75 043 (63.2) 1135 (38.4)
 25.0–29.9 30 464 (25.7) 1057 (35.7)
 ≥30.0 9934 (8.4) 724 (24.5)
Weight >90 kg at first prenatal visit 2968 (1.9) 369 (9.3) <0.01e
Prior newborn weighing ≥4000 g 5596 (5.3) 998 (30.8) <0.01e
Prior stillbirth 2860 (1.5) 104 (2.2) <0.01e
Previous infant death 15 494 (8.3) 474 (10.0) <0.01e
Personal or family history of diabetes mellitus 135 (0.1) 22 (0.5) <0.01e
Chronic hypertension 3923 (2.1) 170 (3.6) <0.01e
Sex of newborn
 Female 92 405 (49.4) 1643 (34.8) <0.01e
 Male 94 712 (50.6) 3074 (65.2)
Abbreviation: BMI, body mass index (calculated as weight in kilograms divided by the square of height in meters).
a
Values are given as median (interquartile range) or number (percentage) unless stated otherwise.
b
Data were available for 174 110 women in the first group and 4291 women in the second group.
c
Data were available for 118 730 women in the first group and 2957 women in the second group.
d
By Wilcoxon rank-sum test.
e
By Pearson χ2 test.
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Table 2
Crude and adjusted odds ratios for predictors of macrosomic newborns in Lusaka, Zambia (n = 4717).
Characteristic Crude OR (95% CI) Adjusted OR (95% CI)a
Maternal age, y
 <20 1.0 1.0
 20–34 3.45 (3.05–3.91) 1.92 (1.29–3.02)
 ≥35 5.36 (4.64–6.21) 1.90 (1.35–2.66)
Maternal education
 None or primary 1.0 1.0
 Secondary and higher 1.20 (1.12–1.27) 1.29 (1.17–1.42)
Parity
 0 1.0 1.0
 1–4 2.75 (2.51–3.01) 1.63 (1.19–2.22)
 ≥5 4.01 (3.51–4.58) 1.86 (1.29–2.67)
Baseline BMI
 <18.5 1.0 1.0
 18.5–24.9 1.20 (0.88–1.64) 0.92 (0.63–1.34)
 25.0–29.9 2.75 (2.01–3.76) 1.72 (1.17–2.52)
 ≥30.0 5.79 (4.22–7.94) 2.88 (1.95–4.24)
Weight >90 kg at first prenatal visitb 5.35 (4.77–5.99)
Prior newborn weighing ≥4000 g 7.97 (7.37–8.63) 7.60 (6.81–8.49)
Prior stillbirth 1.46 (1.20–1.78) 1.03 (0.74–1.42)
Previous infant death 1.24 (1.12–1.36) 1.02 (0.87–1.18)
Personal or family history of diabetes mellitus 6.07 (3.83–9.61) 3.09 (1.36–6.98)
Chronic hypertension 1.73 (1.48–2.03) 1.12 (0.87–1.43)
Sex of newborn
 Female 1.0 1.0
 Male 1.82 (1.71–1.94) 1.95 (1.76–2.15)
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by the square of height in meters); CI, confidence interval; OR,
odds ratio.
a
ORs were adjusted for age, education, parity, BMI, prior newborn weighing ≥4000 g, prior stillbirth, previous infant death, personal or family
history of diabetes, chronic hypertension, and sex of newborn.
b
The generalized linear model accounting for covariance was not applicable.
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Table 3
Pregnancy outcomes for normal birth weight and macrosomic newborns in Lusaka, Zambia (n = 191 834).a
Pregnancy outcome Birth weight 2500–
3999 g (n = 187 117)
Birth weight
≥4000 g (n =
4717)
Crude OR (95% CI) Adjusted OR (95%
CI)b
Mode of delivery
 Spontaneous or assisted vaginal
delivery
178 834 (96.5) 4244 (90.7) 1.0 1.0
 Cesarean delivery 6472 (3.5) 435 (9.3) 2.78 (2.51–3.07) 1.63 (1.35–1.96)
 Cephalopelvic disproportion or dystocia
as indication for Cesarean delivery
1536 (23.8) 148 (34.0) 1.66 (1.35–2.04) 2.88 (1.96–4.24)
 Hypertensive disorders of pregnancy
including eclampsia
10 418 (5.6) 467 (9.9) 1.85 (1.68–2.04) 1.42 (1.23–1.65)
 Perineal laceration 70 (0.0) 4 (0.1) 2.27 (0.83–6.21) 1.97 (0.42–9.19)
 Postpartum hemorrhage 441 (0.3) 16 (0.4) 1.47 (0.89–2.42) 1.07 (0.46–2.47)
 Maternal death 228 (0.1) 8 (0.2) 1.39 (0.69–2.82) 1.13 (0.34–3.67)
 Any other maternal complication 568 (0.3) 14 (0.3) 0.98 (0.58–1.66) 0.97 (0.44–2.12)
 Fresh stillbirth 1115 (0.6) 65 (1.4) 2.33 (1.81–3.00) 2.24 (1.56–3.21)
 Macerated stillbirth 787 (0.4) 39 (0.8) 1.97 (1.41–2.74) 1.38 (0.80–2.37)
 5-min Apgar score <7 1345 (0.8) 49 (1.2) 1.42 (1.07–1.90) 2.03 (1.33–3.11)
 NICU admission 1031 (0.6) 60 (1.3) 2.33 (1.79–3.02) 2.07 (1.32–3.23)
 Early neonatal death 740 (0.4) 19 (0.4) 1.02 (0.65–1.61) 1.23 (0.62–2.42)
Abbreviations: CI, confidence interval; NICU, neonatal intensive care unit; OR, odds ratio.
a
Values are given as number (percentage) unless stated otherwise.
b
ORs were adjusted for age, body mass index, prior newborn weighing ≥4000 g, prior stillbirth, previous infant death, personal or family history of
diabetes, and chronic hypertension.
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